deuterium oxide has been researched along with HIV-Associated Lipodystrophy Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferriolli, E; Guimarães, MP; Navarro, AM; Pfrimer, K | 1 |
| Hellerstein, MK | 1 |
2 other study(ies) available for deuterium oxide and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Doubly Labeled Water Method and Accelerometer for the Measurement of Energy Expenditure in Human Immunodeficiency Virus-Infected Patients.
Topics: Accelerometry; Adult; Anti-Retroviral Agents; Calorimetry, Indirect; Deuterium Oxide; Energy Metabolism; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Predictive Value of Tests; Young Adult | 2017 |
Turnover of adipose components and mitochondrial DNA in humans: kinetic biomarkers for human immunodeficiency virus-associated lipodystrophy and mitochondrial toxicity?
Topics: Adipose Tissue; Animals; Biomarkers; Cell Division; Deuterium Oxide; DNA, Mitochondrial; Gene Expression; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lipid Metabolism; Mass Spectrometry; Mice; Mitochondrial Diseases; Rats | 2003 |